254 related articles for article (PubMed ID: 22184239)
1. Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints.
Pabla N; Bhatt K; Dong Z
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):197-202. PubMed ID: 22184239
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G₂ checkpoint arrest.
Poehlmann A; Habold C; Walluscheck D; Reissig K; Bajbouj K; Ullrich O; Hartig R; Gali-Muhtasib H; Diestel A; Roessner A; Schneider-Stock R
J Cell Mol Med; 2011 Jul; 15(7):1528-41. PubMed ID: 20716119
[TBL] [Abstract][Full Text] [Related]
3. Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900.
Blackwood E; Epler J; Yen I; Flagella M; O'Brien T; Evangelista M; Schmidt S; Xiao Y; Choi J; Kowanetz K; Ramiscal J; Wong K; Jakubiak D; Yee S; Cain G; Gazzard L; Williams K; Halladay J; Jackson PK; Malek S
Mol Cancer Ther; 2013 Oct; 12(10):1968-80. PubMed ID: 23873850
[TBL] [Abstract][Full Text] [Related]
4. DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function.
Löffler H; Bochtler T; Fritz B; Tews B; Ho AD; Lukas J; Bartek J; Krämer A
Cell Cycle; 2007 Oct; 6(20):2541-8. PubMed ID: 17726372
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses.
Martinho RG; Lindsay HD; Flaggs G; DeMaggio AJ; Hoekstra MF; Carr AM; Bentley NJ
EMBO J; 1998 Dec; 17(24):7239-49. PubMed ID: 9857181
[TBL] [Abstract][Full Text] [Related]
6. Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor.
King C; Diaz H; Barnard D; Barda D; Clawson D; Blosser W; Cox K; Guo S; Marshall M
Invest New Drugs; 2014 Apr; 32(2):213-26. PubMed ID: 24114124
[TBL] [Abstract][Full Text] [Related]
7. Checkpoint kinase 1 in DNA damage response and cell cycle regulation.
Patil M; Pabla N; Dong Z
Cell Mol Life Sci; 2013 Nov; 70(21):4009-21. PubMed ID: 23508805
[TBL] [Abstract][Full Text] [Related]
8. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
Lee HJ; Hwang HI; Jang YJ
Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
[TBL] [Abstract][Full Text] [Related]
9. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
10. Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage.
Xu N; Libertini S; Black EJ; Lao Y; Hegarat N; Walker M; Gillespie DA
Oncogene; 2012 Mar; 31(9):1086-94. PubMed ID: 21765472
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation.
Han X; Mayca Pozo F; Wisotsky JN; Wang B; Jacobberger JW; Zhang Y
J Biol Chem; 2015 May; 290(19):12370-8. PubMed ID: 25809478
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
13. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
Demidova AR; Aau MY; Zhuang L; Yu Q
J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
[TBL] [Abstract][Full Text] [Related]
14. Chk1-Mad2 interaction: a crosslink between the DNA damage checkpoint and the mitotic spindle checkpoint.
Chilà R; Celenza C; Lupi M; Damia G; Carrassa L
Cell Cycle; 2013 Apr; 12(7):1083-90. PubMed ID: 23454898
[TBL] [Abstract][Full Text] [Related]
15. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
[TBL] [Abstract][Full Text] [Related]
16. The interaction between checkpoint kinase 1 (Chk1) and the minichromosome maintenance (MCM) complex is required for DNA damage-induced Chk1 phosphorylation.
Han X; Aslanian A; Fu K; Tsuji T; Zhang Y
J Biol Chem; 2014 Aug; 289(35):24716-23. PubMed ID: 25049228
[TBL] [Abstract][Full Text] [Related]
17. DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2.
Zhang WH; Poh A; Fanous AA; Eastman A
Cell Cycle; 2008 Jun; 7(11):1668-77. PubMed ID: 18469532
[TBL] [Abstract][Full Text] [Related]
18. Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death.
Del Nagro CJ; Choi J; Xiao Y; Rangell L; Mohan S; Pandita A; Zha J; Jackson PK; O'Brien T
Cell Cycle; 2014; 13(2):303-14. PubMed ID: 24247149
[TBL] [Abstract][Full Text] [Related]
19. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
Wang FZ; Fei HR; Cui YJ; Sun YK; Li ZM; Wang XY; Yang XY; Zhang JG; Sun BL
Apoptosis; 2014 Sep; 19(9):1389-98. PubMed ID: 24928205
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
